%0 Generic
%A Lopez-Pedrera, C.
%A Munoz-Barrera, L.
%A Escudero Contreras, A.
%A Aguirre-Zamorano, M. A.
%A Ortiz Buitrago, P.
%A Lopez-Medina, C.
%A Calvo Gutierrez, J.
%A Ortega Castro, R.
%A Pilar, F. U.
%A Sanchez-Pareja, I.
%A Abalos-Aguilera, M. C.
%A Barbarroja Puerto, N.
%A Collantes Estevez, E.
%A Perez-Sanchez, C.
%T IDENTIFICATION OF NOVEL BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC AUTOIMMUNE DISEASES THROUGH NEXT GENERATION PROTEOMICS
%D 2022
%@ 0003-4967
%U http://hdl.handle.net/10668/20121
%X Background: Systemic autoimmune diseases such as Rheumatoid Arthritis(RA) and Systemic Lupus Erythematosus (SLE) are characterised by aberrantautoimmune and inflammatory processes, which are directly associated with the development and progression of these disorders. Novel biomarkers associated with the severity of these diseases are needed to better characterise and monitor their progression as well as to develop new and more effective therapeutic strategies.
%K Arthritis, rheumatoid
%K Lupus erythematosus, systemic
%K Reverse transcriptase polymerase chain reaction
%K Correlation of data
%~